Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, ...

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral drugs and monoclonal antibodies that suppress an ...

NIH cuts target $1.6 billion RECOVER initiative to study and improve treatment of long COVID, putting further research gains ...

Megyn Kelly, the American journalist, regrets her decision to get the Covid-19 vaccine, citing an autoimmune diagnosis ...

A newly released report reveals seven U.S. military athletes showed COVID-19 symptoms after the 2019 Military World Games in ...

Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of ...

More than half a decade after the pandemic began, key information on COVID-19's origins continues to dribble out of the U.S.

The following is a summary of “Effect of pre-existing coronavirus antibodies on SARS-CoV-2 infection outcomes in exposed ...

by Timothy McQuiston, Vermont Business Magazine The Vermont Department of Health reported last week that the number of COVID-19 hospitalizations remains low, at under 5 after a spike in January.

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, including antiviral ...